Metabolic Syndrome with Different Antipsychotics: A Multicentre Cross-Sectional Study
By Cem Cerit, Meltem Vural, S ̧ükriye Bos ̧gelmez, Eylem Özten, Ahmet Tamer Aker, Mustafa Yıldız
Duloxetine in Military Posttraumatic Stress Disorder
By Gerardo Villarreal, José M. Cañive, Lawrence A. Calais, Gregory Toney, Ashley K. Smith
Why Do Persons with Bipolar Disorder Stop Their Medication?
By Kavi K. Devulapalli, Rosalinda V. Ignacio, Peter Weiden, Kristin A. Cassidy, Tiffany D. Williams, Roknedin Safavi, Frederic C. Blow, Martha
COMPLICATED CASE HISTORIES
Risperidone Induced Ventricular Tachycardia
By M. Nadeem Mazhar, David S. Resch
The Sex Effects Scale: Pilot Validation in a Healthy Population
By Sidney H. Kennedy, Sakina J. Rizvi, Kari Fulton, Janet Ellis, Lena C. Quilty, Lakshmi Ravindran
Treatment of Pathological Gambling with Naltrexone Pharmacotherapy and Brief Intervention: A Pilot Study
By Tuuli Lahti, Jukka T. Halme, Maiju Pankakoski, David Sinclair, Hannu Alho
Off-Label Second Generation Antipsychotics for Impulse Regulation Disorders: A Review
Albertine Scheltema Beduin, Lieuwe de Haan
Drug Induced Mania in a Boy with High Functioning Autism
By Mustafa Deniz Tutkunkardas, Nahit Motavalli Mukaddes
Effectiveness of Clozapine use in Delaying Hospitalization in Routine Clinical Practice: A 2 year Observational Study
By Kazare Nyakyoma, Richard Morriss
Patient Outcomes With Education, Drug Therapy, and Support: A Study of Venlafaxine ER-Treated Outpatients with Major Depressive Disorder
By Kasia Lobello, Sujana Reddy, Jeff Musgnung, Ronald Pedersen, Philip T. Ninan
Predictive Value of Early Improvement in Bipolar Depression Trials: A Post-hoc Pooled Analysis of Two 8-week Aripiprazole Studies
By D.E. Kemp, J.R. Calabrese, J.M. Eudicone, S. Ganocy, Q.V. Tran, R.D. McQuade, R.N. Marcus, E. Vester-Blokland, R. Owen, B.X. Carlson
Antipsychotic Medication in Adolescents Suffering from Schizophrenia: A Meta-Analysis of Randomized Controlled Trials
By Ignazio Ardizzone, Francesca Nardecchia, Arianna Marconi, Teresa I. Carratelli, Mauro Ferrara
ORIGINAL RESEARCH
Financial Incentives to Improve Adherence to Medication in Five Patients with Schizophrenia in The Netherlands
By Anton B.P. Staring, C.L. Mulder, S. Priebe
The Effectiveness of Long-Acting Injectable Risperidone in a Population of Psychiatric Out-Patients: 1-Year Naturalistic Study
By Rosaria Di Lorenzo, Fiorenza Fiorini, Sonia Santachiara
Signal Detection and Placebo Response in Schizophrenia: Parallels with Depression
By Craig H. Mallinckrodt, Lu Zhang, William R. Prucka, Brian A. Millen